Adenomyosis With Severe Hemorrhage - An Overview

Introduction

Adenomyosis is a gynecologic disorder in which the uterine lining's endometrial tissue grows into the uterus's muscular wall. It causes the uterus to swell and may cause excessive menstrual flow. Juvenile cystic adenomyosis is an uncommon variant of the disease that primarily affects women under 30, and is characterized by more extensive bleeding within myometrial cysts.

What Causes Adenomyosis?

Although the precise etiology of adenomyosis remains undetermined, a variety of theories and risk factors are said to have a role in its development:

• Endometrial Tissue Invasion: It is believed that endometrial cells enter the uterus through the muscle layer, potentially as a result of an opening in the endometrial-myometrial barrier.

• Developmental Origins: According to some experts, abnormal development of embryonic tissue inside the uterus wall may be the source of adenomyosis. Chronic inflammation of the lining of the uterus may facilitate the entry of endometrial cells into the myometrium.

• Hormonal Factors: It is thought that hormonal abnormalities, especially those involving estrogen, contribute to the development and multiplication of adenomyotic tissue.

• Surgical History: Endometrial and myometrial layer disruption from prior uterine procedures, including cesarean sections or fibroid excision, may raise the risk.

• Genetic Predisposition: Given that adenomyosis can run in families, there might be a hereditary component.

What Could Be the Pathophysiology of Adenomyosis With Severe Hemorrhage?

Through different pathways, inappropriate endometrial tissue development within the myometrium causes symptoms. Menstrual contractions are powered by prostaglandin, which is produced by healthy endometrial tissue. Ectopic adenomyosis foci raise prostaglandin levels, which cause dysmenorrhea, the disease's defining feature. Additionally, endometrial growth is driven by estrogen and is the target of pharmacological interventions. Several variables, including increased endometrial surface area, increased vascularization, aberrant uterine contractions, and higher levels of cell signaling molecules, including prostaglandins, eicosanoids, and estrogen, are thought to be responsible for heavy menstrual bleeding. The consequences can be severe if adenomyosis is linked to significant bleeding.

How Is the Condition Confirmed?

• Clinical Examination: An enlarged, painful uterus may be found during a pelvic exam.

• Imaging: An MRI or ultrasound can be used to see the thicker uterine walls and distinguish adenomyosis from other diseases like fibroids.

• Transvaginal Ultrasound: For adenomyosis, transvaginal ultrasonography is the recommended diagnostic imaging modality. Three categories can be used to classify the typical findings, which represent the histopathologic alterations of the disease:

  • Endometrial Infiltration: Myometrial cysts, "lollipop" diverticula (cystic striations), and echogenic striations and nodules are examples of endometrial infiltration.

  • The Proliferation of Smooth Muscles: Myometrial thickening, either focal or widespread, usually affecting the posterior fundus and exhibiting heterogeneous echotexture, which appears as thin, linear shadows that are "Venetian blind."

  • Vascularity: Compared to leiomyomas, which cause vessels to shift, a color Doppler scan of the affected myometrium shows more twisted vessels.

• Biopsy: A biopsy is not as common for adenomyosis as it is for other uterine disorders, but it is nevertheless possible in certain circumstances to confirm the diagnosis.

• Histological Diagnosis: The histologic diagnosis of adenomyosis is the presence of glandular tissue and endometrial stroma in the smooth muscle of the myometrium. There are several ways to define the necessary depth of invasion; some use an absolute measurement ranging from 2.5 to 8 mm, while others use a percentage. Furthermore, several histopathological grading schemes aim to define the general impact of disease.

What Are the Signs Shown by Adenomyosis?

Women with adenomyosis show symptoms like:

• Heavy Menstrual Bleeding (Menorrhagia): This is sometimes the most obvious symptom and can cause a substantial loss of blood, which can occasionally lead to anemia.

• Dysmenorrhea-Related Severe Cramps and Pain: Generally, the pain is more severe than regular monthly cramps.

• Extended Menstrual Periods: Extended periods of menstrual blood loss.

• Pelvic Discomfort: It is possible to have chronic pelvic discomfort or pain that worsens during sexual activity.

• Uterine Enlargement: The uterus may swell up, feeling heavy and sensitive.

How Is Severe Hemorrhage Associated With Adenomyosis Managed?

Adenomyosis-related severe bleeding needs to be treated promptly to avoid consequences like severe anemia. In cases of acute blood loss, transfusions could be required, and iron supplements are frequently recommended to treat long-term blood loss. To establish a treatment plan based on the severity of symptoms, the goal for future fertility, and general health, it is essential to work together with a healthcare expert.

When to Seek Immediate Medical Attention?

Immediate medical care is essential. If experiencing symptoms of severe hemorrhage, such as

• Profuse, unstoppable bleeding.

• Signs of anemia, such as fatigue, dizziness, or fainting.

• Severe pain that is unmanageable with usual pain relief measures.

Why Is It Important to Address Adenomyosis in Child-Bearing Age?

• Adenomyosis potentially interferes with the pregnancy by reducing the implantation rates, inflammation, and distorted architecture of the uterus.

• During pregnancy, adenomyosis can cause complications like miscarriage, particularly in the first trimester, and the risk of preterm birth.

• Though adenomyosis can complicate pregnancy, many women with this condition conceive a healthy child and undergo a healthy pregnancy.

How Is the Condition Managed?

Medical Management:

• Hormonal Treatments: Birth control pills, intrauterine devices (IUDs) with progestin, or gonadotropin-releasing hormone (GnRH) agonists can help manage symptoms by regulating menstrual cycles and reducing bleeding.

• Non-steroidal Anti-inflammatory Drugs (NSAIDs): To relieve pain.

• Tranexamic Acid: This can help reduce menstrual blood loss.

Minimally Invasive Therapy:

• Endometrial Ablation: This procedure destroys the lining of the uterus to reduce bleeding but is not suitable for women who wish to preserve fertility.

• Uterine Artery Embolization (UAE): This blocks blood flow to the adenomyosis areas, reducing symptoms and bleeding.

Surgical Management:

• Hysterectomy: This is the definitive treatment, especially for severe cases that do not respond to other therapies. It involves the removal of the uterus and resolves adenomyosis permanently.

• Adenomyomectomy: Removal of the adenomyotic tissue while preserving the uterus, suitable for women who wish to maintain fertility.

What Happens When Adenomyosis and Hemorrhage Are Left Untreated?

If adenomyosis with severe hemorrhage is left untreated, the serious health consequences faced are

• Iron-Deficiency Anemia: Severe bleeding causes anemia, which, on ignorance, results in heart problems.

• Pelvic Pain: Pelvic pain causes discomfort that interferes with daily activities and quality of life.

• Infertility: As adenomyosis interferes with fertility when left untreated, it causes recurrent miscarriage or implantation failure.

• Symptoms Worsen Over Time: the uterus keeps expanding and causes excruciating pain and bleeding, which ultimately affects the quality of life.

Conclusion

In adenomyosis, the myometrium (the muscle wall of the uterus) is invaded by the endometrial tissue that lines the inside of the uterus. This abnormal tissue can expand the uterus and cause severe cramping, excessive bleeding, and pain during menstruation. Treatment for adenomyosis with extensive bleeding must be multifaceted and can have a substantial impact on quality of life. Consultation with a healthcare professional regarding symptoms might result in a customized treatment plan that addresses the condition's pain and bleeding issues.